OBJECTIVES: Compared with percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG) appears to be a promising revascularization strategy for multivessel coronary disease. Trials comparing these treatments have not used second-generation drugeluting stents (2nd DES). We conducted a retrospective evaluation of both treatments using a propensity score-matched analysis (PSMA).
Coronary artery bypass surgery is superior to second generation drug-eluting stents in three-vessel coronary artery disease: a propensity score matched analysis † 
INTRODUCTION
Coronary artery bypass grafting (CABG) has remained the first-line revascularization strategy in patients with multivessel coronary artery disease (CAD) for several decades [1, 2] . Current European guidelines [3] recommend CABG (class I, level A), which are similar to guidelines set by the American College of Cardiology/American Heart Association [4] (class I, level B) for three-vessel disease regardless of the anatomic complexities of the coronary arteries. Conversely, percutaneous coronary intervention (PCI) is recommended in the case of three-vessel disease if the SYNTAX score is < _22 (class I, level B); otherwise PCI would be harmful for three-vessel disease with a SYNTAX score of > _ 23 (class III, level B) [3] . These guidelines have shown favourable judgments for CABG in revascularization strategies for three-vessel disease. However, PCI has been progressing rapidly, along with newly developed devices such as drug-eluting stents (DES). Several contemporary trials [5, 6] have reported that PCI using DES can reach similar mortality rates compared with those elicited using CABG even though patients had multivessel coronary diseases. Moreover, trials comparing CABG versus PCI have not employed second-generation drugeluting stents (2nd DES). The latter are made of thinner stents coated with more biocompatible polymer and newer 'limus' drugs, which allow less inflammation and a lower rate of restenosis compared with first-generation DES (1st DES). As a result, cardiologists no longer use 1st DES for PCI. However, few trials [7, 8] have compared the outcomes of CABG and PCI using 2nd DES for multivessel CAD. This issue is controversial and encountered frequently in real-world clinical situations. Thus, we conducted a retrospective evaluation to compare outcomes between CABG and PCI using 2nd DES in patients with three-vessel coronary disease.
PATIENTS AND METHODS
The study protocol was approved by the Ethics Committee of Kurashiki Central Hospital (Kurashiki, Japan). The latter waived written informed consent because of the retrospective nature of our study. Between January 2010 and December 2014, 537 patients with three-vessel with/without left main CAD underwent isolated CABG (n = 239) or primary PCI using 2nd DES (n = 298) at our cardiac center. Patients with acute myocardial infarction (MI) were excluded from both groups. Selection of patients to undergo PCI instead of CABG was based on the preference of the patient or the cardiologist. Patients were excluded from the study if they had undergone PCI previously. All PCI patients were diagnosed primarily as having three-vessel disease and treated with 2nd DES in all critical lesions. PCI could have been undertaken as one, two, or more staged procedures. CABG was done at our institution mostly with the off-pump method (OPCAB) using multiple arterial grafts through a median sternotomy. The primary endpoint of the present study was death from any cause. Secondary end-points were cardiac death, MI, repeat target-vessel revascularization (TVR), and stroke during follow-up. 'Stroke' was defined as a central neurologic deficit persisting for >24 h or a new infarcted lesion detected by computed tomography or magnetic resonance imaging of the head. 'MI' was defined according to the definition stated in the Arterial Revascularization Therapy Study [9] .
Data collection and follow-up
Demographic, angiographic, and procedural data were collected from hospital charts or databases. Follow-up was achieved using a telephone questionnaire directly or at an outpatient clinic of our cardiac center (follow-up rate = 99.4%).
Statistical analysis
Continuous variables are expressed as the mean ± standard deviation. A propensity score-matched analysis was done using a multivariable logistic regression model based on: age, sex, diabetes mellitus, hypertension, hyperlipidemia, current smoker, haemodialysis, estimated glomerular filtration rate, previous MI, previous stroke, peripheral arterial disease, low ejection fraction (<40%), SYNTAX score, EuroSCORE I and emergency procedure. Pairs of patients receiving CABG or PCI were derived using 1:1 greedy nearest neighbor matching within one-quarter of the standard deviation of the estimated propensity. This strategy resulted in 168 matched pairs in each group. Clinical characteristics between groups were compared using the Student's t-test for continuous measures and the v 2 test for categorical variables. The Kaplan-Meier method was used to estimate the rate of cumulative events, and differences between groups were assessed using the log-rank test. A Cox proportional-hazards model was constructed to evaluate the hazard ratio for each event in both groups. The balance of measured variables between groups after propensity score-matching was analyzed using a paired t-test for continuous measures and the McNemar test for categorical variables. Differences in the rate of cumulative events after propensity score-matching were analyzed using the stratified Cox procedure.
Results were considered significant at P < 0.05. Statistical analyses were carried out using SPSS v20 (IBM, Armonk, NY, USA) and R Statistical Software v3.3.2 (R Development Core team, 2016). Table 1 shows patient profiles before and after propensity scorematching. Before propensity score-matching, the CABG group contained sicker patients, with renal dysfunction, more peripheral vascular disease, lower ejection fraction, and current smokers, than those in the PCI group. However, patients in the CABG group were significantly younger (P = 0.005) with fewer emergency cases (P = 0.019) than patients in the PCI group. As a result, the EuroSCORE I in both groups was similar (5.5 ± 7.2 vs 5.5 ± 3.1 for CABG vs PCI, P = 0.976). SYNTAX scores between the two groups were also similar (28.7 ± 8.3 vs 28.3 ± 9.4 for CABG vs PCI, P = 0.571). After propensity score-matching, both groups were well matched in all parameters. CABG data are shown in Table 2 . Eighty-four percent of patients underwent OPCAB, with a mean of two arterial grafts per patient. The mean number of grafts per lesion is shown. The left internal thoracic artery (LITA) was used in 96% of cases, right internal thoracic artery (RITA) in 55%, and radial artery (RA) in 30%. PCI data are shown in Table 3 . The mean number of implanted stents in each case was 5.0 ± 2.0. The mean number of stents per lesion is shown. A one-staged procedure was done in 55% of PCI cases, two-staged in 43%, and more than three stages in 2%. The stent used most frequently (43% of cases) was an Everolimus-eluting stent (Xience; Abbott Vascular, Santa Clara, CA, USA).
RESULTS
The median duration of follow-up for CABG and PCI groups was 955 and 1026 days, respectively (P = 0.07). Figure 1 shows that the Kaplan-Meier cumulative all-cause mortality was similar in both groups before propensity score-matching [hazard ratio (HR) 1.15; 95% confidence interval (95% CI), 0.69-1.93; P = 0.586] but, when both clinical backgrounds were adjusted, PCI was associated with a significantly higher risk of death compared with CABG (HR 2.71; 95% CI 1.14-6.46; P = 0.019). The incidence of cardiac death (Fig. 2) was similar in both groups before propensity score-matching (HR 2.02; 95% CI 0.72-5.68; P = 0.171) but tended to be higher in the PCI group after propensity score-matching (HR 4.0; 95% CI 0.85-18.84; P = 0.058; not significant). Cumulative incidences of MI and stroke were not different between CABG and PCI before or after propensity score-matching (Figs 3 and 4) . The risk of TVR after PCI (Fig. 5 ) was significantly higher than that after CABG even though PCI involved use of newer 2nd DES (HR 4.63; 95% CI 2.43-8.82; P < 0.001 before propensity score-matching; HR 9.0; 95% CI 2.73-29.67; P < 0.001 after propensity score-matching).
DISCUSSION
The present study elicited three main findings. First, CABG is superior to PCI in terms of reducing the incidence of TVR even though 2nd DES are used in PCI. Second, all-cause mortality and cardiac death of patients with three-vessel disease are similar after CABG or PCI in daily selection of patients at our cardiac center. However, if patient backgrounds with regard to both revascularization strategies are adjusted, CABG is the more favourable strategy in patients with three-vessel disease than PCI using 2nd DES. Finally, the cumulative incidence of stroke is similar after CABG undertaken mainly OPCAB compared with that of PCI.
Several randomized prospective studies [10, 11] comparing CABG with PCI as a coronary revascularization strategy have been published over recent decades. In most of those trials, bare-metal stents (BMS) and 1st DES were used for PCI. Only one randomized prospective trial compared CABG with PCI using 2nd DES in patients with multivessel coronary diseases [7] . The Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-eluting Stent Implantation in the Treatment of Patients with Multivessel Coronary Artery Disease (BEST) trial enrolled 880 patients, of which 438 patients were assigned randomly to the PCI group and 442 patients to the CABG group, in 27 cardiac centers in East Asia. There were no significant differences in all-cause death, cardiac death, MI, or stroke between the two groups, but the incidence of repeat revascularization was significantly higher after PCI than after CABG. Those results were congruent with the result before propensity score-matching in the present study. However, all-cause mortality was higher in the PCI group than in the CABG group after propensity score- matching in our study. The BEST trial included patients with less severe disease patients and less anatomic complexity of multivessel CAD than those in our study. The EuroSCORE and SYNTAX scores in the BEST trial were 2.9 ± 2.0 in PCI, 3.0 ± 2.1 in CABG and 24.2± 7.5 in PCI, 24.6 ± 8.1 in CABG, respectively, which were relatively healthier than those in the present study. Although our study was a retrospective evaluation, the patients included only three-vessel CAD and were based on more real-world scenarios (including more complex CAD).
In the present study, surgical revascularization was undertaken mainly OPCAB. Recent randomized trials [12, 13] concluded that OPCAB did not show clear clinical benefits compared with CABG using cardiopulmonary bypass (CPB). In the Randomized On/Off Bypass (ROOBY) trial [12] , OPCAB had even worse composite outcomes during 1-year follow-up and poor graft patency than did patients in the CABG group using cardiopulmonary bypass (CPB). The CABG Off or On Pump Revascularization Study (CORONARY) trial [13] , the largest randomized clinical trial (RCT) of OPCAB versus conventional CABG, involving 79 centers in 19 countries, showed no significant differences in the 30-day rate of death, MI, stroke, or renal failure in the two surgical strategies. However, several clinical studies [14, 15] have provided favourable results of OPCAB over conventional CABG to reduce the incidence of stroke. Puskas et al. [14] conducted a retrospective analysis of 42 477 patients from the National Adult Cardiac database of the Society of Thoracic Surgeons, and concluded that there was a significant reduction of stroke in patients undergoing OPCAB compared with conventional CABG. With regard to stroke prevention, OPCAB could be beneficial because it attenuates the chance of aorta-related stroke from aortic cannulation, which is one of the positive benefits of OPCAB. In fact, the BEST trial [7] and the CREDO-Kyoto registry [16] revealed no significant difference in stroke rate between the PCI group and the OPCAB group.
Multiple arterial grafting is associated with improved survival and reduced requirement of reintervention compared with grafting of a single internal thoracic artery (ITA) plus the saphenous vein [17, 18] . The CABG group used a mean of two arterial grafts because we considered multiple arterial grafting if a patient was aged <80 years. In our grafting strategy, the second arterial graft, including the RITA and RA, were anastomosed mostly to the circumflex coronary artery. Previously, we reported that the RITA and RA provided equivalent outcomes if used in conjunction with the left internal thoracic artery (LITA) [19] , a result that was a similar to that from other studies [20, 21] . The prospective randomized Radial Artery Patency and Clinical Outcomes (RAPCO) study [20] found no significant differences in the 6-year survival or event-free survival between RITA and RA configurations. Di Mauro et al. [21] also noted an equivalent 8-year survival between RITA and RA as the second arterial graft. Currently, the importance of multiple arterial grafting, including both internal thoracic arteries (BITA), is supported strongly by society guidelines, such as those of the Society of Thoracic Surgeons, American College of Cardiology/American Heart Association [22] , European Society of Cardiology, and the European Association for Cardio-Thoracic Surgery [3] . The long-term benefits of CABG are related to the protection provided by the bypass conduits. Arterial graft conduits, rather than venous grafts, maximize this surgical benefit. Moshkovitz et al. [23] reported significant benefits of CABG with multiple arterial grafting over PCI based on an observational retrospective study of 226 CABG patients with BITA grafting and 271 PCI patients with 1st DES. In their study, the 5-year reintervention-free survival (P = 0.000 by log-rank test) and major adverse cardiovascular events-free survival (P = 0.001) were significantly better in the CABG group using BITA. Furthermore, Habib et al. [24] cautioned cardiac surgeons that a conventional single-arterial CABG showed similar long-term survival outcomes to those of PCI using DES. In their observational comparison of 8402 patients with multivessel CAD, when multiple arterial grafting was applied for CABG, the survival of CABG was significantly higher than that of PCI with the DES group (95.6% vs 86.3% at 5 years and 89.8% vs 82.8% at 9 years; P < 0.001). In contrast, when single arterial grafting was applied, survival after CABG was the same as that of PCI with DES (85.1% vs 83.3% at 5 years and 69.1% vs 74.5% at 9 years; P = 0.615).
Numerous RCTs and meta-analyses have reported that 2nd DES are superior to 1st DES with regard to reducing the rates of stent thromboses and restenosis [25, 26] . Sarno et al. [25] conducted a pooled analysis of 34 147 patients treated by PCI with 2nd DES (n = 4811), 1st DES (n = 4271), or BMS (n = 25 065). 2nd DES elicited a lower incidence of late stent thrombosis (HR 1.52; P = 0.21) than 1st DES (HR 2.88; P < 0.01) compared with BMS. Bangalore et al. [26] reported that 2nd DES reduced the risk of MI and death strongly when compared with 1st DES in their meta-analysis of 258 544 patients-years from 126 randomized trials. There is no doubt that use of 2nd DES has improved clinical outcomes significantly with PCI compared with the era of 1st DES. However, the present study demonstrated that the superiority of CABG using multiple arterial grafting is retained compared with PCI using 2nd DES for patients with three-vessel disease.
The present study had several limitations. First, this was a retrospective comparison with propensity score-matching to minimize the bias in patient selection, but unobserved confounders (e.g. frailty) remained. A RCT would be ideal, but a retrospective study with propensity score-matching could be acceptable if a sufficient number of RCTs has not been conducted yet. Second, the number of diseased coronary arteries is important, but anatomic complexity may be more important for determination of optimal treatment for patients with multivessel CAD. The complexity of coronary diseases also affects the completeness of revascularization of CABG and PCI. Incomplete revascularization in CABG is associated with better outcomes than in incomplete revascularization in PCI [27] . However, our study did not detail the completeness of both revascularization treatments. Third, our study involved only a Japanese population at a single cardiac center. Fourth, the number of patients treated by PCI (298) was larger than the number of patients undergoing CABG (239) for revascularization of three-vessel disease. This difference can be explained by the attitudes of physicians and patients in Japan. The CABG:PCI ratio in Japan is up to 1:7-15 [28, 29] which is remarkably high compared with that in Western countries (e.g. 1:3-4 in the USA [30] ). To ascertain the suitable revascularization method for patients with CAD, a heart-team approach should be used, as recommended in recent guidelines (American College of Cardiology Foundation/American Heart Association guideline: class I) [22] .
In conclusion, if the backgrounds of patients with three-vessel coronary diseases undergoing CABG or PCI are adjusted by propensity score-matching, CABG is associated with better survival and fewer repeat revascularizations than PCI using 2nd DES at mid-term results.
